# A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches

> **NCT00203216** · NA · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 31 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** levetiracetam
- **PROCEDURE:** Transcranial Magnetic Stimulation

## Key facts

- **NCT ID:** NCT00203216
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2005-01
- **Final completion:** 2005-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2011-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203216, "A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00203216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*